CNTGCentogene N.V.

Nasdaq centogene.com


$ 0.44 $ 0.02 (5.05 %)    

Tuesday, 14-May-2024 15:28:29 EDT
QQQ $ 448.30 $ -0.62 (-0.14 %)
DIA $ 395.58 $ 1.12 (0.28 %)
SPY $ 523.16 $ 2.39 (0.46 %)
TLT $ 91.84 $ 0.51 (0.56 %)
GLD $ 219.17 $ -0.28 (-0.13 %)
$ 0.4201
$ 0.44
$ 0.00 x 0
$ 0.00 x 0
$ 0.44 - $ 0.44
$ 0.36 - $ 1.98
103,016
na
11.59M
$ 0.33
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

Core News & Articles

CENTOGENE to receive license fee providing Evotec with R&D license to complete next phase of pre-clinical researchCompanies...

 centogene-receives-non-compliance-notification-letter-dated-march-27-2024-from-nasdaq

In accordance with Listing Rule 5810(c)(3)(A) of the Nasdaq Listing Rules, the Company has a period of 180 calendar days from t...

Core News & Articles

Centogene N.V. (NASDAQ:CNTG), the essential life science partner for data-driven answers in rare and neurodegenerative diseases...

 centogene-collaborates-on-research-published-in-science-showing-immunopathological-landscape-of-human-pre-tcr-deficiency

CENTOGENE N.V. (NASDAQ:CNTG) (the "Company"), the essential life science partner for data-driven answers in rare and ne...

 centogene-says-it-is-exploring-a-range-of-strategic-alternatives-focused-on-sustainable-long-term-value-creation-for-the-benefit-of-its-stakeholders

The company received a staff determination letter (the "Letter") on Feb. 27, 2024, from the Listing Qualifications Depa...

 centogene-and-the-laboratory-of-human-genetics-of-infectious-diseases-at-institut-imagine-announced-rare-disease-research-collaboration-specific-targets-of-the-collaboration-were-not-disclosed

As part of the collaboration, CENTOGENE and the Lab will leverage the CENTOGENE Biodatabank, which contains over 70 million uni...

 centogene-says-reached-its-initial-recruitment-and-genetic-testing-milestone-in-observational-efront-study

Having met this milestone, CENTOGENE will continue to work with its extensive network of 30,000 physicians and enroll patients ...

 centogene-expands-multiomic-diagnostic-portfolio-with-newly-launched-transcriptomic-offering

Centogene N.V. (NASDAQ:CNTG), the essential life science partner for data-driven answers in rare and neurodegenerative diseases...

 centogene-receives-nasdaq-non-compliance-notification-regarding-minimum-market-value-of-publicly-held-shares-deficiency

 Centogene N.V. (NASDAQ:CNTG) ("we" or the "Company"), the essential life science partner for data-driven answe...

 why-franklin-covey-shares-are-trading-higher-by-25-here-are-other-stocks-moving-in-thursdays-mid-day-session

Gainers Sigilon Therapeutics, Inc. (NASDAQ: SGTX) shares climbed 523.8% to $24.25 after Eli Lilly agreed to acquire the com...

 why-cormedix-are-trading-lower-by-22-here-are-20-stocks-moving-premarket

Gainers Eco Wave Power Global AB (NASDAQ: WAVE) shares surged 123% to $3.48 in pre-market trading after dropping over 8% on ...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION